Related Experiment Video
Updated: Jun 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Predictivity of the Prognostic Nutritional Index and Systemic Inflammation Index for All-Cause In-Hospital Mortality
Sibel Cavdar1, Sumru Savas2, Sezai Tasbakan3
1Division of Geriatrics, Department of Internal Medicine, İzmir City Hospital, 35540 İzmir, Türkiye.
Insights
The prognostic nutritional index (PNI) and systemic immune inflammation index (SII) predict COVID-19 mortality in adults but not in older patients. Age significantly impacts the predictive accuracy of these inflammatory markers.
Area of Science:
- Medical Science
- Immunology
- Gerontology
Background:
- The prognostic nutritional index (PNI) and systemic immune inflammation index (SII) are established predictors of COVID-19 severity and mortality.
- Age-related physiological changes, including inflammaging and comorbidities, may alter the predictive performance of these indices in older adults.
- This study investigates age-specific differences in the predictive value of PNI and SII for COVID-19 mortality.
Purpose of the Study:
- To compare the predictive accuracy of PNI and SII for mortality in hospitalized COVID-19 patients across different age groups.
- To determine if age influences the association between PNI, SII, and COVID-19 mortality.
Main Methods:
- Retrospective analysis of 407 hospitalized COVID-19 patients (March 2020 - December 2020).
- Calculation of PNI and SII within 48 hours of admission.
- Stratification into age groups: <65 years and ≥65 years.
- Receiver operating characteristic (ROC) curve analysis to assess predictive performance.
Main Results:
- In patients <65 years, PNI (AUC=0.706) and SII (AUC=0.697) showed fair predictive accuracy for mortality.
- In patients ≥65 years, PNI (AUC=0.515) and SII (AUC=0.500) demonstrated no significant predictive accuracy for mortality.
- The study included 197 older patients (48.4%) and 210 younger patients (51.6%).
Conclusions:
- PNI and SII exhibit fair predictive capability for mortality in younger adult COVID-19 patients.
- The predictive value of PNI and SII for COVID-19 mortality is diminished in older geriatric patients.
- Age is a critical factor influencing the utility of PNI and SII as prognostic markers in COVID-19.
Abstract:
Background: The prognostic nutritional index (PNI) and the systemic immune inflammation index (SII) have been used as simple risk-stratification predictors for COVID-19 severity and mortality in the general population. However, the associations between these indices and mortality might differ due to age-related changes such as inflammaging and several comorbid conditions in older patients. Therefore, we aimed to compare the predictivity of the PNI and SII for mortality among hospitalized older patients and patients under 65 years old. Methods: Patients hospitalized with COVID-19 from March 2020 to December 2020 were retrospectively included. The PNI and SII were calculated from hospital records within the first 48 h after admission. Data were evaluated in the whole group and according to age groups (≥65 < years). Receiver operating characteristic curves were drawn to evaluate the predictivity of the PNI and SII. Results: Out of 407 patients included in this study, 48.4% (n = 197) were older patients, and 51.6% (n = 210) were under 65 years old. For mortality, the area under the curve (AUC) of the PNI and SII in the adult group (<65 years) was 0.706 (95% CI 0.583-0.828) (p = 0.003) and 0.697 (95% CI 0.567-0.827) (p < 0.005), respectively. The AUC of the PNI and SII in the older group was 0.515 (95% CI 0.427-0.604) (p = 0.739) and 0.500 (95% CI 0.411-0.590) (p = 0.993). Conclusions: The accuracy of the PNI and SII in predicting mortality in adult COVID-19 patients seemed to be fair, but no association was found in geriatric patients in this study. The predictivity of the PNI and SII for mortality varies according to age groups.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Cancer Survival Analysis
Current Trends in Nursing I

